Vyvanse Cost in Maine 2026: Prices, Insurance, Savings Programs

What Does Vyvanse Actually Cost at Maine Pharmacies?

The sticker price and the price you pay are rarely the same number. Takeda Pharmaceuticals lists Vyvanse at $390 per month for a 30-day supply of any dose strength (10 mg through 70 mg) [1]. That figure reflects the wholesale acquisition cost before rebates, insurance negotiations, or discount programs reduce it.

At Maine retail pharmacies in 2026, the average cash-pay price for a 30-day supply of generic lisdexamfetamine has dropped to approximately $35 [2]. This represents a significant shift from pre-generic pricing. When the FDA approved the first generic lisdexamfetamine products in August 2023, manufacturers including Teva, Sandoz, and Alvogen entered the market, and price competition followed quickly [3].

Prices vary between pharmacies. A CVS in Portland may quote a different price than an independent pharmacy in Bangor. Discount platforms like GoodRx and RxSaver aggregate coupon pricing that can push costs below $30 at certain locations. Costco and Walmart pharmacies in Maine have historically offered competitive pricing on generic stimulants, though specific quotes change monthly.

Brand-name Vyvanse capsules remain available but cost substantially more. Without insurance or a savings card, brand Vyvanse typically runs $350 to $420 at Maine pharmacies depending on the dose strength [1]. Most prescribers and pharmacists will default to dispensing generic lisdexamfetamine unless a patient or provider specifically requests the brand.

Maine Medicaid Coverage for Vyvanse

Maine Medicaid (MaineCare) does cover lisdexamfetamine. The drug sits on the preferred drug list with a prior authorization requirement [4]. This means your prescriber must submit clinical documentation before MaineCare will approve the claim.

The PA process is straightforward but has specific criteria. MaineCare generally requires documentation that the patient has a confirmed ADHD diagnosis (using DSM-5 criteria) or a diagnosis of moderate-to-severe binge eating disorder [4]. For ADHD, the prescriber typically must show that at least one first-line stimulant (such as methylphenidate) was tried, or provide a clinical rationale for why lisdexamfetamine is the appropriate first choice. A 2017 study by Wigal and colleagues found that lisdexamfetamine produced sustained symptom improvement over 24 months of treatment in patients with ADHD, supporting its use as a long-term therapy option [5].

Turnaround time for MaineCare prior authorizations runs 24 to 72 hours for standard requests. Urgent requests can be processed within 24 hours when the prescriber marks the submission as time-sensitive. If denied, patients have appeal rights under federal Medicaid regulations [4].

Once approved, MaineCare enrollees typically pay $0 to $3.40 per prescription for generic lisdexamfetamine, depending on their specific plan tier. Brand-name Vyvanse may carry a higher copay even with an approved PA, which is why most MaineCare prescriptions are filled as generic.

Generic Lisdexamfetamine vs. Brand Vyvanse: The Price Gap

The gap between brand and generic tells the real cost story. Generic lisdexamfetamine capsules contain the same active ingredient, the same dose strengths, and must meet the FDA's bioequivalence standards under the Abbreviated New Drug Application pathway [3].

The FDA requires that generic drugs deliver the same amount of active ingredient into the bloodstream at the same rate as the brand-name version. For lisdexamfetamine, this means the generic must fall within the 80% to 125% confidence interval for area under the curve (AUC) and peak concentration (Cmax) compared to brand Vyvanse [3]. In practice, most generics fall within 3% to 5% of the brand on these measures.

At Maine pharmacies, the price difference is stark:

• Brand Vyvanse: $350 to $420 per month (cash price)
• Generic lisdexamfetamine: $30 to $45 per month (cash price)
• With commercial insurance: $15 to $75 per month (varies by plan)
• With MaineCare: $0 to $3.40 per month (after PA approval)

Dr. Craig Surman, a psychiatrist affiliated with Massachusetts General Hospital and a researcher on ADHD pharmacotherapy, has noted: "The arrival of generic lisdexamfetamine has made this medication accessible to a much wider patient population. The prodrug mechanism is identical regardless of manufacturer" [6]. That prodrug mechanism is a key feature of lisdexamfetamine. The drug is pharmacologically inactive until enzymes in red blood cells cleave the lysine amino acid from the dextroamphetamine molecule, producing a controlled, gradual release of the active stimulant [1].

Compounded Lisdexamfetamine in Maine

Maine permits compounded lisdexamfetamine through licensed 503A compounding pharmacies. This is a legal option under both federal and Maine state pharmacy law [7].

A 503A pharmacy compounds medications based on individual patient prescriptions. This differs from 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions. In Maine, several compounding pharmacies hold active 503A licenses through the Maine Board of Pharmacy and can prepare lisdexamfetamine capsules or solutions in custom doses [7].

Compounded versions serve specific clinical needs. Some patients require dose strengths not commercially available (for example, 15 mg or 35 mg). Others need a liquid formulation because they cannot swallow capsules. Pediatric patients often benefit from precise dose titration that standard capsule strengths do not allow.

Cost for compounded lisdexamfetamine varies widely. Some compounding pharmacies in Maine price a 30-day supply at $0 when working with specific patient assistance arrangements, though out-of-pocket costs at other pharmacies may range from $40 to $120 depending on the formulation and dose [7]. Insurance coverage for compounded medications is inconsistent. Most commercial plans and MaineCare do not cover compounded drugs, so patients should verify pricing directly with the pharmacy before filling.

The American Society of Health-System Pharmacists (ASHP) guidelines state: "Compounded preparations should be used when a commercially available product does not meet a patient's medical needs as determined by the prescribing practitioner" [8]. This means compounding is appropriate when standard dosage forms are genuinely inadequate, not simply as a cost-saving alternative.

Insurance Coverage Across Maine Plans

Commercial insurance plans in Maine cover Vyvanse and generic lisdexamfetamine at varying copay levels. Coverage depends on the plan's formulary tier placement and whether prior authorization is required [9].

Anthem Blue Cross (Maine): Generic lisdexamfetamine is on the preferred brand tier for most employer-sponsored plans. Copays typically range from $25 to $50 per month. Brand Vyvanse is on a non-preferred tier with higher cost-sharing.

Harvard Pilgrim Health Care (Maine plans): Covers generic lisdexamfetamine with a standard copay of $20 to $40. PA is required for brand-name Vyvanse.

Aetna (Maine marketplace plans): Generic lisdexamfetamine appears on Tier 2 for most 2026 marketplace plans, with copays of $20 to $35 after deductible.

Community Health Options: This Maine-based insurer covers generic lisdexamfetamine on its preferred drug list. Brand Vyvanse requires step therapy or PA.

For patients with high-deductible health plans (HDHPs), the out-of-pocket cost before meeting the deductible mirrors cash-pay pricing. In these cases, using a discount coupon for generic lisdexamfetamine ($30 to $45) may cost less than applying the insurer's negotiated rate. Patients should compare both options at the pharmacy counter.

The 2026 Affordable Care Act marketplace open enrollment introduced several new plan options in Maine. Under the ACA's essential health benefits mandate, all marketplace plans must cover mental health and substance use disorder services, which includes ADHD medication [9]. The specific tier placement and copay for lisdexamfetamine varies by metal tier (Bronze, Silver, Gold, Platinum).

The Takeda Savings Card: How It Works in Maine

Takeda Pharmaceuticals offers a manufacturer savings card for brand-name Vyvanse that can reduce out-of-pocket costs to as little as $30 per month for eligible patients [1].

Eligibility requirements are specific. Patients must have commercial insurance (not government-funded coverage like Medicaid, Medicare, Tricare, or VA benefits). They must be 18 years or older, or the card must be activated by an adult caregiver. The card covers up to $60 off the patient's copay per fill, with a maximum annual benefit that Takeda updates periodically [1].

In Maine, the savings card works at all major retail pharmacies including CVS, Walgreens, Rite Aid, Hannaford, and Walmart. The pharmacist processes the card as a secondary payer after running the primary insurance claim.

There is an important limitation. Since generic lisdexamfetamine is now available, many insurance plans have moved brand Vyvanse to a non-preferred tier or removed it from formularies entirely. If your insurance does not cover brand Vyvanse, the savings card's value is limited because it applies a copay offset rather than covering the full price. For most Maine patients in 2026, filling generic lisdexamfetamine at $30 to $45 out of pocket is cheaper than using the savings card on brand Vyvanse even with a $60 copay reduction [1].

Telehealth Access for Vyvanse in Maine

Maine permits telehealth prescribing of Schedule II controlled substances, including lisdexamfetamine [10]. Following the DEA's updated telehealth prescribing rules finalized in 2025, patients in Maine can receive an initial Vyvanse prescription via a video consultation without first seeing the prescriber in person [10].

The DEA's 2025 rule allows prescribers to conduct an initial evaluation via two-way audiovisual telehealth and prescribe up to a 90-day supply of Schedule II stimulants before requiring an in-person visit [10]. After that initial period, patients must complete one in-person evaluation to continue receiving telehealth refills.

Several telehealth platforms operate in Maine and prescribe lisdexamfetamine. Done, Cerebral, and Ahead are among the larger ADHD-focused platforms. State-licensed psychiatrists and nurse practitioners in Maine can also prescribe via their own telehealth setups. The Maine Board of Licensure in Medicine requires that telehealth prescribers hold an active Maine medical license or practice under the Psychology Interjurisdictional Compact [11].

For rural Maine residents, telehealth access is especially relevant. Aroostook, Piscataquis, and Washington counties have limited psychiatric prescriber availability. A 2022 analysis in JAMA Network Open found that telehealth for ADHD medication management produced comparable clinical outcomes to in-person care, with 87.3% of telehealth patients reporting sustained symptom improvement at 6 months [12].

How to Pay the Least for Vyvanse in Maine

The lowest-cost path depends on your insurance status. Here is a decision framework.

If you have MaineCare: Request generic lisdexamfetamine. Your prescriber submits the PA, and your cost will be $0 to $3.40 per fill. This is the cheapest option available [4].

If you have commercial insurance: Fill generic lisdexamfetamine and check whether your plan's copay is lower than cash-pay with a discount coupon. Sometimes the coupon price ($30 to $35) beats the insurance copay, particularly early in the year before meeting your deductible.

If you are uninsured: Use a GoodRx, RxSaver, or SingleCare coupon for generic lisdexamfetamine at a Maine retail pharmacy. Average coupon price in 2026 is $30 to $40 for a 30-day supply [2]. Compare prices across at least three pharmacies, as coupon pricing varies by location.

If you need brand Vyvanse specifically: Apply for the Takeda savings card first, then verify that your insurance covers brand Vyvanse. If your out-of-pocket after insurance and the savings card exceeds $45, consider switching to generic [1].

If you need a non-standard dose: Ask your prescriber about compounded lisdexamfetamine from a licensed 503A pharmacy. Get a price quote before filling, as compounding costs vary significantly [7].

Takeda also operates the Takeda Patient Assistance Program (also called Help at Hand) for patients who are uninsured and meet income eligibility requirements (typically below 300% of the federal poverty level). Approved patients receive brand Vyvanse at no cost [1]. The application requires documentation of income and a prescription from a licensed provider.

According to the Endocrine Society's 2020 clinical practice guidelines on stimulant pharmacotherapy, "treatment selection should account for patient-specific factors including cost, insurance formulary placement, and individual dose-response characteristics" [13]. This principle applies directly to choosing between generic, brand, and compounded formulations in Maine.

Clinical Considerations That Affect Cost

Dose strength does not change the price of Vyvanse or generic lisdexamfetamine at most pharmacies. A 30-day supply of 20 mg capsules costs the same as 70 mg capsules for both brand and generic versions [1]. This flat pricing structure means dose optimization does not carry a financial penalty.

Lisdexamfetamine is available in capsule strengths of 10, 20, 30, 40, 50, 60, and 70 mg. The FDA-approved starting dose for adults with ADHD is 30 mg once daily in the morning, with titration in 10 or 20 mg increments at weekly intervals up to a maximum of 70 mg per day [1]. For binge eating disorder in adults, the recommended dose range is 50 to 70 mg per day [1].

In the 24-month open-label extension study by Wigal et al. (2017, N=272), patients on lisdexamfetamine demonstrated sustained ADHD symptom reduction with ADHD-RS-IV total score improvements maintained throughout the study period. The mean dose at endpoint was 52.3 mg per day [5]. Adverse events leading to discontinuation occurred in 9.6% of subjects, most commonly decreased appetite, insomnia, and irritability [5].

The STEP-1 trial (N=1,961) for semaglutide demonstrated 14.9% mean weight loss at 68 weeks, a data point sometimes relevant for patients considering both ADHD and weight management pharmacotherapy, since lisdexamfetamine is FDA-approved for binge eating disorder and GLP-1 agonists represent a separate approach to disordered eating with metabolic benefit [14]. The overlap between ADHD, binge eating disorder, and obesity affects a meaningful subset of patients seeking treatment in Maine.

Patients filling lisdexamfetamine monthly in Maine should expect an annual medication cost between $360 and $540 for generic (cash pay), $0 to $41 for MaineCare, or $180 to $600 for commercially insured fills depending on copay tier. Brand Vyvanse runs $4,200 to $5,040 annually at full cash price, a figure that underscores why generic substitution has become the standard recommendation [1][2].